Background: Identifying biomarkers for early detection of hepatocellular carcinoma [HCC] remains quite challenging. In this study we aimed to estimate the number of TIE2-expressing monocytes [TEMs] cells, which display pro-tumoral activities and are defined as CD14+, TIE2+, and angiopoietin-2; and its potential use as a possible diagnostic marker in HCC patients complicating HCV induced cirrhosis.
Introduction
Hepatocellular carcinoma [HCC] has an increasing incidence all over the world, being the second most common worldwide cancer among males and the sixth among females [1, 2] . It is also the second most common cause of cancer deaths [3, 4] . HCC has a very high mortality rate due to limited treatment options in the vast majority of cases [1] . In Egypt, liver cancer accounts for around 11.75% of gastrointestinal malignancies and 1.68% of the total malignancies. Also, HCC constitutes 70.48% of all hepatic malignancies among the Egyptian population [5] . The etiology of HCC is multifactorial, with many infectious and noninfectious health problems.
These include hepatitis viral infections (hepatitis B virus
[HBV] and hepatitis C virus [HCV]), alcoholic liver cirrhosis and non-alcoholic fatty liver disease [NAFLD] .
However, the pathogenesis of HCC is not yet fully understood [6] . The limited current treatment options available, and treatment resistance, especially chemotherapy, remain the major challenges in the management of such cases. The cause of this is usually due to late diagnosis of HCC, and so there is an increasing need for identifying suitable biomarkers for early detection of HCC; aiming to improve the treatment outcomes [7] . Macrophages display several pro-tumorigenic functions that have important roles in cancer initiation and progression [8] . Tumor-associated macrophages [TAMs] are heterogeneous macrophage cells that can be subdivided into different populations according to either high or low expression of major histocompatibility complex [MHC] class II. TAMs remain poorly understood and might differ according to tumor type and localization [9] . Angiogenesis, or the formation of new blood vessels, is an essential process in the progression, extension, and distant metastasis of many tumors. This is a known dependent risk factor of hematological malignancies and was also proven for many solid tumors [10] . [12] . Tie2 expressed on proangiogenic macrophages are involved in tumor angiogenesis and intravasation of malignant cells and subsequent metastasis [13] . The angiopoietin Ang/Tie2 kinase signaling pathway is an important angiogenic signaling axis which subsequently ends with poor outcome and recurrence in cancer patients [14, 15] .
CD14 levels are increased in some inflammatory conditions and may reflect disease severity [16] . It is also found to correlate with the degree of liver inflammation in non-alcoholic steatohepatitis [NASH] patients [17] .
The study aimed to examine the number of TEM in the blood of HCC patients complicating HCV induced liver cirrhosis(TEM); defined as CD14+, TIE2+, and angiopoietin-2 in HCC cases and its value as a possible diagnostic marker in.
Methods
This study was carried out on 112 Patients: A p-value of less than 0.05 was considered significant in all statistical tests used in the study.
Results
A total of 112 patients were included in our study and 38 healthy controls classified into 3 groups. Using the items which showed significant results in table [3] in a multivariate regression analysis showed that only HB is significant from routine investigations, while CD14, TIE2, and Ang-2 could be considered as independent predicting factors for HCC. Moreover, analysis of the p-value and the odd's ratio showed that CD14 has higher predictive power for HCC.
Analysis of the ROC curve [ Figure 2 ] showed that the cut-off point for CD14+is14. 25 
Discussion
Due to the increasing incidences of many liver disorders that can develop HCC and due to the limited treatment options and the poor efficacy of most of them in later stages of the disease course; it is mandatory to find suitable screening methods for early detection of HCC in order to improve the outcome of this major health hazard [7] . Tumor-associated macrophages (TAMs) differ from monocytes by being able to secrete many substances including cytokines, growth factors necessary for tumor growth and angiogenic factors as a vascular endothelial growth factor (VEGF) which promoting tumor angiogenesis [19] .
We found the following in our data analysis, Concerning the correlation between laboratory data, there was no significant correlation with serum Ang-2 levels in HCC groups, except a negative significant correlation between platelet counts and serum Ang-2.
Also, we found a significant and positive correlation between serum Ang-2 and serum AFP in HCC patients group. This was in discordance with Scholz et al [25] and Youssef et al [21] who failed to find any correlation between both markers among patients with HCC.
Concerning the percentage of the circulating TEMs: All with highly statistically significant analyses, TEM frequency [CD14+ and TIE2+] was superior to Ang-2 levels as a diagnostic marker for HCC and these results are consistent with Matsubara et al [26] who found that ROC curve analysis revealed that TEM was superior to both AFP and Ang-2 levels as a diagnostic marker for HCC. We used the binary logistic regression analysis to identify predictors of an unfavorable outcome and we found that CD14+, TIE2+, and-2 could be used as predictive of such.
Conclusion
Proangiogenic markers TEM and serum Ang-2 levels were elevated more in HCC patients than in patients with liver cirrhosis and in normal control and Also, we can conclude that CD14+, TIE2+, and Ang-2 could be used as predictive of bad outcome
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